Evidence map›Paper›PMID 26337671›Full record

ArticleMalaria journal2015

Monitoring changes in malaria epidemiology and effectiveness of interventions in Ethiopia and Uganda: Beyond Garki Project baseline survey.

Tarekegn A Abeku, Michelle E H Helinski, Matthew J Kirby, Takele Kefyalew, Tessema Awano, Esey Batisso, Gezahegn Tesfaye, James Ssekitooleko, Sarala Nicholas, Laura Erdmanis and 14 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Malaria journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 47 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Effect of IvermectinMalaria journal · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors at 8 institutions in 3 countries.

Tarekegn A AbekuMalaria Consortium, London, UK. t.abeku@malariaconsortium.org.
Michelle E H HelinskiMalaria Consortium, London, UK. m.helinski@malariaconsortium.org.
Matthew J KirbyMalaria Consortium, London, UK. mattkirby.tanga@gmail.com.
Takele KefyalewMalaria Consortium, Addis Ababa, Ethiopia. t.kefyalew@malariaconsortium.org.
Tessema AwanoMalaria Consortium, Addis Ababa, Ethiopia. t.awano@malariaconsortium.org.
Esey BatissoMalaria Consortium, Addis Ababa, Ethiopia. e.batisso@malariaconsortium.org.
Gezahegn TesfayeMalaria Consortium, Addis Ababa, Ethiopia. g_tesfaye@yahoo.com.
James SsekitoolekoMalaria Consortium, Kampala, Uganda. j.ssekitooleko@malariaconsortium.org.
Sarala NicholasMalaria Consortium, London, UK. s.nicholas@malariaconsortium.org.
Laura ErdmanisMalaria Consortium, London, UK. laura.erdmanis@rothamsted.ac.uk.
Angela NalwogaMedical Research Council/Uganda Virus Research Institute, Uganda Research Unit on AIDS, Entebbe, Uganda. angela.nalwoga@mrcuganda.org.
Chris BassRothamsted Research, Harpenden, UK. chris.bass@rothamsted.ac.uk.
Stephen CoseMedical Research Council/Uganda Virus Research Institute, Uganda Research Unit on AIDS, Entebbe, Uganda. stephen.cose@lshtm.ac.uk.
Ashenafi AssefaEthiopian Public Health Institute, Addis Ababa, Ethiopia. ashyaega@yahoo.com.
Zelalem KebedeMalaria Consortium, Addis Ababa, Ethiopia. z.kebede@malariaconsortium.org.
Tedila HabteMalaria Consortium, Addis Ababa, Ethiopia. t.habte@malariaconsortium.org.
Vincent KatambaNational Malaria Control Programme, Ministry of Health, Kampala, Uganda. katambaz@gmail.com.
Anthony NuwaMalaria Consortium, Kampala, Uganda. a.nuwa@malariaconsortium.org.
Stella Bakeera-SsaliMalaria Consortium, Kampala, Uganda. stellabssali@yahoo.co.uk.
Sarah C AkirorMalaria Consortium, Kampala, Uganda. connie_akiror@yahoo.co.uk.
Irene Kyomuhangi
Agonafer TekalegneMalaria Consortium, Addis Ababa, Ethiopia. a.tekalegne@malariaconsortium.org.
Godfrey MagumbaMalaria Consortium, Kampala, Uganda. g.magumba@malariaconsortium.org.
Sylvia R MeekMalaria Consortium, London, UK. s.meek@malariaconsortium.org.
Malaria Consortium · GBMalaria Consortium · UGEthiopian Public Health Institute · ETLondon School of Hygiene & Tropical Medicine · GBMinistry of Health · UGRothamsted Research · GBUganda Virus Research Institute · UGUniversity of London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundScale-up of malaria interventions seems to have contributed to a decline in the disease but other factors may also have had some role. Understanding changes in transmission and determinant factors will help to adapt control strategies accordingly.

methodsFour sites in Ethiopia and Uganda were set up to monitor epidemiological changes and effectiveness of interventions over time. Here, results of a survey during the peak transmission season of 2012 are reported, which will be used as baseline for subsequent surveys and may support adaptation of control strategies. Data on malariometric and entomological variables, socio-economic status (SES) and control coverage were collected.

resultsMalaria prevalence varied from 1.4 % in Guba (Ethiopia) to 9.9 % in Butemba (Uganda). The most dominant species was Plasmodium vivax in Ethiopia and Plasmodium falciparum in Uganda. The majority of human-vector contact occurred indoors in Uganda, ranging from 83 % (Anopheles funestus sensu lato) to 93 % (Anopheles gambiae s.l.), which is an important factor for the effectiveness of insecticide-treated nets (ITNs) or indoor residual spraying (IRS). High kdr-L1014S (resistance genotype) frequency was observed in A. gambiae sensu stricto in Uganda. Too few mosquitoes were collected in Ethiopia, so it was not possible to assess vector habits and insecticide resistance levels. ITN ownership did not vary by SES and 56-98 % and 68-78 % of households owned at least one ITN in Ethiopia and Uganda, respectively. In Uganda, 7 % of nets were purchased by households, but the nets were untreated. In three of the four sites, 69-76 % of people with access to ITNs used them. IRS coverage ranged from 84 to 96 % in the three sprayed sites. Half of febrile children in Uganda and three-quarters in Ethiopia for whom treatment was sought received diagnostic tests. High levels of child undernutrition were detected in both countries carrying important implications on child development. In Uganda, 7-8 % of pregnant women took the recommended minimum three doses of intermittent preventive treatment.

conclusionMalaria epidemiology seems to be changing compared to earlier published data, and it is essential to have more data to understand how much of the changes are attributable to interventions and other factors. Regular monitoring will help to better interpret changes, identify determinants, modify strategies and improve targeting to address transmission heterogeneity.

Indexed as

MalariaAdolescentAdultAnemiaAnimalsAnophelesChildChild, PreschoolCross-Sectional StudiesEthiopiaFemaleFeverHealth Knowledge, Attitudes, PracticeHumansInfantInfant, NewbornInsecticides

Identifiers

PMID26337671
PMCPMC4559172
OpenAlexW2116453323

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.